PANSY COOPER: Open Payments
NPI 1215046339 · CONWAY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,576 in 74 payments from 22 companies in 2025. Trend: 2023 $2,082 · 2024 $2,117 · 2025 $1,576
Food & beverage: $1,576
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 14 | $266 |
| Novo Nordisk Inc | 5 | $223 |
| Lilly USA, LLC | 7 | $193 |
| ABBVIE INC. | 14 | $160 |
| Phathom Pharmaceuticals, Inc. | 2 | $145 |
| AstraZeneca Pharmaceuticals LP | 6 | $100 |
| Ardelyx, Inc. | 4 | $81 |
| PFIZER INC. | 4 | $66 |
| Abbott Laboratories | 3 | $54 |
| Amgen Inc. | 2 | $30 |
Products named: TRELEGY ELLIPTA, MOUNJARO, Ozempic, VOQUEZNA, IBSRELA, VRAYLAR, FREESTYLE LIBRE 3, FARXIGA.
Industry payments across SC — which companies pay providers there.
